Bayer CropScience Limited announced the approval of its unaudited financial results for the quarter and half-year ended September 30, 2026. Alongside these results, the Board of Directors declared an interim dividend of Rs 90 per equity share. This dividend will be paid on November 30, 2026, to eligible shareholders recorded by November 12, 2026. The financial results were reviewed by Deloitte Haskins & Sells LLP.
Bayer CropScience Announces Financial Results and Dividend
Bayer CropScience Limited has officially released its unaudited financial results for the quarter and the half-year ended September 30, 2026. The Board of Directors, in their meeting held on November 03, 2026, approved these results and the accompanying limited review report from the statutory auditors, Deloitte Haskins & Sells LLP.
Interim Dividend Declared
A significant outcome of the board meeting was the declaration of an interim dividend. The company announced an interim dividend of Rs 90/- per equity share, with a face value of Rs 10/- each, for the Financial Year 2026-27. The payment for this dividend is scheduled for Monday, November 30, 2026. Entitlement for the dividend will be based on the company’s Register of Members as of the Record Date, which is Thursday, November 12, 2026.
Financial Highlights
The unaudited financial statements reveal key figures for the periods presented. For the quarter ended September 30, 2026, Revenue from Operations stood at Rs 12,507 million, with Profit Before Tax at Rs 2,114 million and Profit for the period/year at Rs 1,662 million. For the six months ended September 30, 2026, Revenue from Operations reached Rs 30,857 million, with Profit Before Tax at Rs 6,135 million and Profit for the period/year at Rs 4,878 million. The company reported paid-up equity share capital of Rs 449 million and reserves (excluding Revaluation Reserve) of Rs 31,394 million as of September 30, 2026. Earnings per share (basic and diluted, not annualized) for the quarter and six months ended September 30, 2026, were Rs 36.98 and Rs 108.54 respectively.
Segment Information and Other Income
The company operates under a single reportable business segment, ‘Agri Care’. The nature of the business is seasonal, meaning quarterly figures may not reflect the full year’s performance. Other income for the quarter ended September 30, 2026, included a gain on divestment of marketing rights for formulated products amounting to Rs 639 million.
Board Meeting Details
The Board Meeting commenced at 04:00 p.m. (IST) and concluded at 05:15 p.m. (IST) on November 03, 2026.
Source: BSE
